- Home
- IPHA vs KRMD Comparison
IPHA vs KRMD Comparison
Compare IPHA & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- KRMD
- Stock Information
- Founded
- IPHA 1999
- KRMD 1980
- Country
- IPHA France
- KRMD United States
- Employees
- IPHA N/A
- KRMD N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- KRMD Medical/Dental Instruments
- Sector
- IPHA Health Care
- KRMD Health Care
- Exchange
- IPHA Nasdaq
- KRMD Nasdaq
- Market Cap
- IPHA 160.1M
- KRMD 134.3M
- IPO Year
- IPHA 2019
- KRMD N/A
- Fundamental
- Price
- IPHA $2.11
- KRMD $3.34
- Analyst Decision
- IPHA Strong Buy
- KRMD Strong Buy
- Analyst Count
- IPHA 1
- KRMD 4
- Target Price
- IPHA $11.00
- KRMD $4.63
- AVG Volume (30 Days)
- IPHA 13.4K
- KRMD 117.5K
- Earning Date
- IPHA 09-11-2025
- KRMD 08-06-2025
- Dividend Yield
- IPHA N/A
- KRMD N/A
- EPS Growth
- IPHA N/A
- KRMD N/A
- EPS
- IPHA N/A
- KRMD N/A
- Revenue
- IPHA $20,831,349.00
- KRMD $35,083,740.00
- Revenue This Year
- IPHA $278.51
- KRMD $18.16
- Revenue Next Year
- IPHA $70.16
- KRMD $14.60
- P/E Ratio
- IPHA N/A
- KRMD N/A
- Revenue Growth
- IPHA N/A
- KRMD 19.65
- 52 Week Low
- IPHA $1.29
- KRMD $1.86
- 52 Week High
- IPHA $3.51
- KRMD $5.05
- Technical
- Relative Strength Index (RSI)
- IPHA 60.15
- KRMD 48.00
- Support Level
- IPHA $1.71
- KRMD $3.32
- Resistance Level
- IPHA $2.63
- KRMD $3.61
- Average True Range (ATR)
- IPHA 0.14
- KRMD 0.16
- MACD
- IPHA 0.03
- KRMD -0.02
- Stochastic Oscillator
- IPHA 41.83
- KRMD 51.79
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).